Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Current Leases (2022 - 2025)

Historic Current Leases for Rani Therapeutics Holdings (RANI) over the last 4 years, with Q3 2025 value amounting to $1.0 million.

  • Rani Therapeutics Holdings' Current Leases fell 2560.28% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 2560.28%. This contributed to the annual value of $1.5 million for FY2024, which is 10320.33% up from last year.
  • As of Q3 2025, Rani Therapeutics Holdings' Current Leases stood at $1.0 million, which was down 2560.28% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Rani Therapeutics Holdings' Current Leases registered a high of $1.5 million during Q4 2024, and its lowest value of $650000.0 during Q1 2022.
  • Its 4-year average for Current Leases is $1.0 million, with a median of $1.0 million in 2022.
  • Its Current Leases has fluctuated over the past 5 years, first plummeted by 2862.82% in 2023, then soared by 10320.33% in 2024.
  • Rani Therapeutics Holdings' Current Leases (Quarter) stood at $1.0 million in 2022, then dropped by 28.63% to $718000.0 in 2023, then surged by 103.2% to $1.5 million in 2024, then decreased by 28.1% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q3 2025, $1.2 million for Q2 2025, and $1.3 million during Q1 2025.